Alastin Skincare Announces Issuance of Third U.S. Patent for Its Products

Posted By American Med Spa Association, Thursday, December 19, 2019

ALASTIN Skincare, Inc.—a specialty aesthetics company dedicated to developing and marketing clinically-tested, physician-dispensed skin care products—has announced that the United States Patent and Trademark Office has issued a third U.S. Patent covering its science and products. U.S. Patent No. 10,493,011 is titled, "Peptide Compositions and Methods for Ameliorating Skin Laxity and Body Contour." This patent is directed to the composition and uses related to Alastin's TransFORM Body Treatment, when used alone as well as when used in conjunction with body-shaping procedures.
Read more at PR Newswire >>